Pharma services businesses are facing growing pressure from consolidation, evolving client expectations and the rapid adoption of AI across the drug development value chain. Hear from L.E.K.’s Andre Valente, and panel members as they discuss how CROs, medical imaging specialists and pharma services providers are adapting their business models to maintain scalability and differentiation. The session explores the impact of AI on clinical development and operational delivery, alongside the commercial and strategic levers helping pharma services companies improve efficiency, strengthen competitive positioning and drive growth in an increasingly tech-driven market.
Footage courtesy of Healthcare Business International 2026 (HBI 2026).
